In contrast to results from protein expression in our TMA clinical samples, HDAC9 was expressed at higher levels in EMC (p = 0.002) not in serous-type and KAT6a median expression was only borderline higher in SC (p = 0.070) (Fig 5). This evidence concerns the gene HDAC9 and extraskeletal myxoid chondrosarcoma.